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Abstract
Baseline injury categorization is important to traumatic brain injury (TBI) research
and treatment. Current categorization is dominated by symptom-based scores that
insufficiently capture injury heterogeneity. In this work, we apply unsupervised
clustering to identify novel TBI phenotypes. Our approach uses a generalized
low-rank model (GLRM) model for feature selection in a procedure analogous to
wrapper methods. The resulting clusters reveal four novel TBI phenotypes with
distinct feature profiles and that correlate to 90-day functional and cognitive status.
1 Introduction
Traumatic brain injury (TBI) is a leading cause of death and disability in the United States, with
an estimated 2.8 million new cases annually [1]. In the United States alone, more than 5.2 million
individuals currently live with TBI-related disabilities spanning a diverse array of neurobehavioral
symptoms such as cognitive, emotional, and motor impairments [2].
Significant heterogeneity exists within the spectrum of TBI relative to cause, severity, pathology,
and prognosis. This heterogeneity represents a major challenge to phenotype categorization which
is important to TBI research directed at understanding the underlying physiological mechanisms
of injury and recovery, and therapeutic development. Currently, TBI is predominantly categorized
by symptom-based scores such as the Glasgow Coma Scale (GCS), which is the primary selection
criteria for inclusion in most TBI clinical trials [3]. However, there is a consensus among TBI
researchers that GCS derived categories are insufficient to capture the complexity of brain injury and
do not adequately correlate with long term outcomes [3, 4].
Unsupervised machine learning is a promising method for data-driven phenotype discovery that may
improve current TBI categorization. Unsupervised methods have previously been used to identify
patient sub-populations for several diseases [5–7] and have recently been applied within the limited
context of mild TBI [8, 9]. In the work presented here, we sought to extend the use of unsupervised
learning in TBI to identify sub-populations with homogeneous clinical characteristics for a broad
range of injury severity. Our approach, described in detail below, uses a two-stage pipeline. In the
first stage, we perform automated feature selection via generalized low-rank model (GLRM) analysis
in a manner analogous to wrapper methods used in supervised learning contexts. In the second stage,
the selected feature set is used to cluster the entire dataset.
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2 Methods
2.1 Study cohort data
Analysis was conducted on data from the Citicoline Brain Injury Treatment Trial (COBRIT;
NCT00545662), a clinical trial of 1,213 TBI patients [10, 11] 1. Patients were between the ages of
18 and 70 years old, had been diagnosed with a non-penetrating TBI, and had a positive baseline
CT scan. Baseline data was acquired prior to injury or within 24 hours after injury and included CT
scans, physiological measurements, vital signs, medical history, demographics, laboratory test results,
drug screening, and injury information. Where reported, multiple physiological measurements were
averaged into a single value. All categorical features were consolidated into a maximum of three
categories based on category frequency and dummy coded. Patients with missing values for any
baseline feature were excluded, leaving 991 for this study. Outcome data included 12 assessments
of 90 day functional and cognitive status. Only patients with complete outcome data were used for
analysis of cluster to outcome association (n = 771 at 90 days).
2.2 Generalized Low-Rank Model feature selection
A GLRM decomposes an m× n matrix,A, into matricesX andY such thatXY is approximately
equal toA under the constraint that the number, k, of linearly independent columns inX (i.e. the
rank) satisfies k < n (see Figure 1). Importantly for biomedical applications, GLRM’s can represent
high-dimensional data of mixed data types in a transformed lower-dimensional space [12]. We used a
GLRM to decompose the patient data matrix,A, composed of m patient rows and n clinical feature
columns. We fixed our low-rank model at rank k = 2, and used quadratic and hinge loss functions to
approximate numerical and binary features, respectively [12]. We applied L1-norm regularization on
Y to reduce the size of the feature set contributing to the low rank decomposition, resulting in the
following loss function:
L (A,XY) =

m∑
i=1
n∑
j=1
1/σ2j (Aij −XiYj)2 + γ
n∑
j=1
||Yj ||1 ifA:,j ∈ R
m∑
i=1
n∑
j=1
max (0, 1−Aij ·XiYj) + γ
n∑
j=1
||Yj ||1 ifA:,j ∈ {0, 1}
(1)
where the L1-regularization parameter, γ, is greater than zero, andA:,j indicates column j ofA. The
quadratic loss function was scaled by the inverse variance, 1/σ2j , of each feature, j, to compensate
for unequal scaling in different features. Regularization produces a column-sparse matrix,Y, where
the number of non-zero columns, d, is small relative to the total column number, n. IfY:,j is a zero
vector, then feature j fromA is not used in the formulation of any of the low-rank features which
suggests it was relatively uninformative in approximatingA [13–15]. Therefore, for a given choice
of γ, we select the d features from the original input space for which there is at least one non-zero
entry in the column Y:,j . In this manner, the GLRM is utilized for feature reduction, rather than
transformation into a lower dimensional space.
Figure 1: A GLRM model decomposes the original matrix,A, into matricesX andY. AssumingA
is a patient data matrix with rows representing patients and columns representing clinical features,
the rows ofY can be viewed as a set of new low-rank (LR) features composed of combinations of
the original features and the rows ofX as patient representations in the low-rank feature space.
2.3 Clustering method
Given a feature set, we calculated the pairwise dissimilarity between observations using Gower’s
measure [16] to form a dissimilarity matrix. Gower’s measure was selected because it accommodates
1data available through https://fitbir.nih.gov/
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mixed data types. Weights were added to binary features in pairwise Gower’s coefficient calcula-
tions such that both binary and numerical features were weighted proportionally on average. The
partitioning around medoids (PAM) algorithm was used to cluster the dissimilarity matrix [17].
2.4 Cross-validation feature selection procedure
To avoid over-fitting, we implemented a K-fold cross-validation feature selection procedure to tune
the GLRM regularization parameter, γ (see Algorithm 1). For each fold, an optimal parameter is
determined on the trainig folds. Features are then selected using GLRM on the validation fold. The
final feature set was taken as the intersection of features selected across the K validation folds.
Algorithm 1: Cross-validation feature selection. Functions: update_results - stores best values in
dictionary; GLRM_features - feature selection per section 2.2; PAM - clustering per section 2.3
Input :data: D; initial gamma: γ0; gamma step size: γstep; complete feature list: all_features
1 final_features = all_features;
2 for k in [1, . . . ,K] do
3 validation_set = fold(k,D); train_set =
⋃K
j=1,j 6=k fold(j, D);
4 increment_γ = True; best_score = -1; γ = γ0; best_train = {};
5 while increment_γ do
6 increment_γ = False; features = GLRM_features(train_set, γ);
7 for nc in [nmin, . . . , nmax] do
8 clusters = PAM(train_set, features, nc); score = silhouette(clusters);
9 if score > best_score then
10 increment_γ = True; best_score = score;
11 update_results(best_train, k, γ, score, clusters, features);
12 end
13 end
14 γ += γstep;
15 end
16 best_score = -1; best_validation = {};
17 features = GLRM_features(validation_set, γ); # use γ from best_training;
18 for nc in [nmin, . . . , nmax] do
19 clusters = PAM(validation_set, features, nc); score = silhouette(clusters);
20 if score > best_score then
21 best_score = score;
22 update_results(best_validation, k, γ, score, clusters, features);
23 end
24 end
25 final_features = final_features
⋂
best_validation[’features’, ’k’] # best features fold(k)
26 end
2.5 Cluster analysis
Training and validation cluster stability was assessed by comparing the similarity of cluster member-
ship between observation pairs in the training and validation folds, respectively, with their cluster
membership in the full dataset using the Pairwise Similarity Index. The Pairwise Similarity Index for
two equal length sets of clustering labels, Set A and Set B, is the percent of total observation pairs
that belong to the same cluster in both Set A and Set B.
2.6 Statistical Analysis
To compare differences in feature values between clusters, group-wise comparisons were assessed us-
ing the Kruskal-Wallis test for non-parametric one-way analysis of variance. When the Kruskal-Wallis
test indicated overall significance, the Holm multiple comparison test was used to determine specific
group differences where applicable. Pearson’s chi-squared test was used to compare distributions of
categorical variables. Statistical comparisons were considered significant when p values were < 0.05
or as determined by the Holm’s test statistic for multiple comparisons.
3
3 Results
From the 98 features available in the COBRIT dataset, our feature selection process retained 13:
net fluid intake; heart rate; blood count measures of hematocrit, hemoglobin, platelets, white blood
cells; blood levels of glucose and the liver enzyme aspartate aminotransferase (AST); and clotting
indicators prothrombin time (PT), partial thromboplastin time (PTT) and PT International Normalized
Ratio (INR); presence of abnormal mesencephalic cisterns on the CT scan (whether blood-filled,
compressed or obliterated); indicator of falling as injury mechanism. The necessity of each feature
was evaluated by randomly shuffling its values between patients, clustering the data and comparing
the results to the clusters obtained using the non-shuffled values via the Jaccard similarity and pairwise
similarity index. This process was repeated 500 times. Only INR was found to be unnecessary and
was removed for the final analysis.
The full dataset of 991 patients was clustered using the remaining 12 features resulting in four
distinct patient phenotypes, as shown in Figure 2. Statistically significant differences between clusters
were found for all 12 baseline features (Appendix Table 1). At 90 days, there were significant
differences between clusters on 9 out of 12 of the outcome assessment scores (Appendix, Table 2).
For comparison, when patients were grouped by their GCS score at baseline, the current clinical
standard, no significant baseline feature or 90 day outcome differences were detected between groups.
Figure 2: T-SNE projection of clusters found with PAM clustering and GLRM feature selection.
Cluster patient membership counts: (A, 314), (B, 204), (C, 286), and (D,187).
4 Discussion & conclusion
We identified 4 TBI patient phenotypes using unsupervised machine learning. Each phenotype
possess a unique baseline feature profile which corresponded to differences in long-term outcomes.
Comparatively, when categorized by GCS score, distinct feature profiles are not observed and
categories did not correlate with long-term outcomes. Methodologically, we used a GLRM to identify
important features from the original input space. This is advantageous for biomedical applications
because it enables feature reduction to control over-fitting, while retaining interpretable clinical
features. The selected features plausibly influence TBI outcome. Platelet and hemoglobin counts,
hematocrit, PT, PTT, & net fluid intake contribute to coagulation which is common in TBI and is
associated with poor outcomes [18–20]. High net fluid intake, low complete blood count measures and
prolonged PT/PTT duration are indicative of possible hemorrhage [21], which may have occurred in
patients with abnormal mesencephalic cisterns which were more represented in subtype B. Abnormal
cistern imaging, elevated AST levels, and increased white blood cell counts have been associated
with TBI in previous research [8, 22, 23]. Falling as injury cause, the only selected non-physiological
feature, is associated with intracranial pressures that differ from other injury mechanisms [24, 25].
Study limitations include: all patients had positive CT findings, which is not true of all TBIs; baseline
features did not include genetic data or other neuroimaging modalities; phenotype profile and patient
outcome realations are only correlative. These areas are considerations for our future research.
Our results demonstrate that unsupervised machine learning may advance TBI translational research.
With refinement, we anticipate that data-derived patient phenotypes will supplement existing clinical
assessments for TBI patient classification in clinical trials and provide clinical decision support.
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Appendix
Table 1: Injury baseline feature profile comparison between TBI phenotypes discovered by unsuper-
vised learning with GLRM feature selection. Kruskal-Wallis Test p-value < 0.0001 for all continuous
valued features. Pearson’s Chi Squared Test p-value < 0.001 for all binary features.
Subtype A Subtype B Subtype C Subtype D
Clinical Features
Continuous Median IQR Median IQR Median IQR Median IQR
Platelet count (1000/µL) 219.0 80.0 181.5 91.3 216.0 80.0 177.4 71.1
Hemoglobin (g/dL) 14.1 1.8 10.3 2.2 13.0 1.9 11.1 1.9
AST (IU/L) 33.0 19.0 83.5 96.3 50.0 60.5 40.0 28.8
Net Fluid Intake (L) 1.7 1.5 5.7 4.1 3.1 2.2 3.4 2.4
Heart Rate (bpm) 81.0 14.3 103.5 17.8 97.5 15.5 79.5 12.9
Glucose (mg/dL) 120.5 29.8 152.8 45.1 136.0 35.4 134.8 38.3
White Blood Cell Count
(1000/µL) 11.6 5.4 16.5 6.9 14.3 5.2 12.5 5.5
Hematocrit (%) 41.0 4.5 32.5 5.5 39.0 5.0 35.3 4.9
Prothrombin Time (sec) 13.0 2.9 14.8 3.1 10.9 2.9 13.8 3.4
Partial Thromboplastin
Time (sec) 26.5 4.3 28.5 5.5 25.0 3.9 27.0 4.4
Clinical Features
Binary % Count % Count % Count % Count
Abnormal Mesencephalic
Cisterns (CT Finding) 15.9% (50) 44.1% (90) 25.2% (72) 63.1% (118)
Fall Injury Mechanism 28.3% (89) 90.0% (184) 78.3% (224) 35.2% (66)
Table 2: 90-day functional and cognitive status comparison between injury baseline TBI phenotypes
discovered by unsupervised learning with GLRM feature selection. Kruskal-Wallis Test p-value
indicated in last column.
Subtype A Subtype B Subtype C Subtype D
Primary Outcomes Median IQR Median IQR Median IQR Median IQR p-value
Glasgow Outcome Scale
Extended 6 1 4 3 5 2 4 3 <0.0001
California Verbal
Learning Test 49 17 39 21 47 20 42 20 <0.0001
Processing Speed Index 26 28 24 30 29 27 23.5 30.3 0.0044
Trial Making A 43 18 29 40 39 21 37 27.3 <0.0001
Trail Making B 42 19 33 40 39 28 37.5 26.5 <0.0001
Digit Span 9 3 8 3 9 4 9 3.8 0.0328
Stroop Part 1 45.5 15.3 51 18 49 17 48 16 0.0005
Stroop Part 2 112 42 112 63 110 52 106.5 52.5 0.5319
Controlled Oral Word
Association Test 38 14 31 15 34 15 34.5 14.3 <0.0001
Secondary Outcomes Median IQR Median IQR Median IQR Median IQR p-value
Disability Rating Scale 0 1 4 6 1 3 1 4 <0.0001
Satisfaction with Life
Scale 24 12 21 10.8 23 11 23 11 0.6702
Brief Symptoms
Inventory-18 Global
Severity Index
56 19.8 57 14.8 55 18 56 15.5 0.7566
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